Selected article for: "infectious disease and specific sequence"

Author: Freije, Catherine A.; Sabeti, Pardis C.
Title: Detect and destroy: CRISPR-based technologies for the response against viruses
  • Cord-id: dc9d1uvo
  • Document date: 2021_4_28
  • ID: dc9d1uvo
    Snippet: Despite numerous viral outbreaks in the last decade, including a devastating global pandemic, diagnostic and therapeutic technologies remain severely lacking. CRISPR-Cas systems have the potential to address these critical needs in the response against infectious disease. Initially discovered as the bacterial adaptive immune system, these systems provide a unique opportunity to create programmable, sequence-specific technologies for detection of viral nucleic acids and inhibition of viral replic
    Document: Despite numerous viral outbreaks in the last decade, including a devastating global pandemic, diagnostic and therapeutic technologies remain severely lacking. CRISPR-Cas systems have the potential to address these critical needs in the response against infectious disease. Initially discovered as the bacterial adaptive immune system, these systems provide a unique opportunity to create programmable, sequence-specific technologies for detection of viral nucleic acids and inhibition of viral replication. This review summarizes how CRISPR-Cas systems—in particular the recently discovered DNA-targeting Cas12 and RNA-targeting Cas13, both possessing a unique trans-cleavage activity—are being harnessed for viral diagnostics and therapies. We further highlight the numerous technologies whose development has accelerated in response to the COVID-19 pandemic.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acid cleavage: 1
    • absence presence and acid detection: 1
    • absence presence and acid target: 1
    • absence presence and activity target: 1, 2
    • absence presence and acute chronic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • absence presence and acute lymphoblastic leukemia: 1
    • absence presence and additional study: 1, 2, 3, 4
    • absence presence and adoptive transfer: 1, 2
    • absence presence and luciferase expression: 1
    • absence presence and lung epithelial cell: 1
    • absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and lymphoblastic leukemia: 1, 2
    • absence presence and lysis buffer: 1, 2, 3, 4, 5
    • absence presence and magnetic bead: 1, 2, 3
    • access open and activity target: 1
    • access open and acute chronic: 1, 2
    • access open and additional study: 1, 2, 3, 4
    • access open and additional understanding: 1
    • access open and lung tissue: 1